Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-28 Sale | 2022-09-30 4:23 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer | 100,000 | $41.23 | $4,122,670 | 1,324,700 (Indirect) | View |
| 2022-06-08 Sale | 2022-06-10 5:13 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer | 100,000 | $41.56 | $4,155,900 | 945,830 (Indirect) | View |
| 2022-05-27 Sale | 2022-05-31 5:23 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer | 75,000 | $41.08 | $3,081,008 | 1,045,830 (Indirect) | View |
| 2022-05-19 Sale | 2022-05-23 4:57 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer | 75,000 | $40.44 | $3,033,128 | 1,120,830 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-08-12 Gift | 2022-09-30 4:23 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer | 2,400 | $0 | 1,324,700 (Indirect) | View |
| 2021-09-10 Gift | 2021-12-30 6:03 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 5,128 | $0 | 481,270 (Indirect) | View |